Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors

Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases. This study describes changes in use, technique, and survival in a population-based cohort. The study included 38,060 patients with hematologi...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 31; no. 19; p. 2437
Main Authors:	Hahn, Theresa, McCarthy, Jr, Philip L, Hassebroek, Anna, Bredeson, Christopher, Gajewski, James L, Hale, Gregory A, Isola, Luis M, Lazarus, Hillard M, Lee, Stephanie J, Lemaistre, Charles F, Loberiza, Fausto, Maziarz, Richard T, Rizzo, J Douglas, Joffe, Steven, Parsons, Susan, Majhail, Navneet S
Format:	Journal Article
Language:	English
Published:	United States 01.07.2013
Subjects:	Adolescent Adult Age Factors Aged Canada - epidemiology Child Child, Preschool Cohort Studies Female Hematologic Neoplasms - mortality Hematologic Neoplasms - surgery Hematopoietic Stem Cell Transplantation - utilization Hodgkin Disease - mortality Hodgkin Disease - surgery Humans Infant Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - surgery Lymphoma, Non-Hodgkin - mortality Lymphoma, Non-Hodgkin - surgery Male Middle Aged Myelodysplastic Syndromes - mortality Myelodysplastic Syndromes - surgery Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery Retrospective Studies SEER Program Survival Analysis Survival Rate Transplantation, Homologous United States - epidemiology Unrelated Donors Canada United States
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!